trending Market Intelligence /marketintelligence/en/news-insights/trending/iyrncwsy4ke3qv_z3urwlq2 content esgSubNav
In This List

Abeona adds 2 directors, replaces another

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Abeona adds 2 directors, replaces another

Abeona Therapeutics Inc. appointed CEO F. Carsten Thiel to be a director on its board.

Thiel, who was appointed CEO in March, replaces Timothy Miller who will continue to serve as the company's chief scientific officer and president.

The Dallas-based clinical-stage biopharmaceutical company also appointed Stefano Buono and Richard Van Duyne to the board.